QPW
ONCT

Quantum Private Wealth’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Quantum Private Wealth’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,187
Closed -$17.4K – 196
2024
Q3 		$17.4K Sell
13,187
-13,715
-51% -$66.2K 0.01% 186
2024
Q2 		$204K Sell
26,902
-904
-3% -$7.79K 0.07% 174
2024
Q1 		$250K Buy
+27,806
New +$244K 0.09% 157
2023
Q4 		– Sell
-22,959
Closed -$138K – 190
2023
Q3 		$138K Buy
22,959
+150
+0.7% +$1.06K 0.07% 171
2023
Q2 		$157K Sell
22,809
-65
-0.3% -$429 0.07% 169
2023
Q1 		$359K Sell
22,874
-344
-1% -$6.77K 0.19% 118
2022
Q4 		$464K Buy
23,218
+150
+0.7% +$2.99K 0.29% 88
2022
Q3 		$411K Buy
23,068
+285
+1% +$6.11K 0.26% 99
2022
Q2 		$505K Buy
22,783
+525
+2% +$11.7K 0.3% 80
2022
Q1 		$618K Buy
22,258
+250
+1% +$9.1K 0.27% 76
2021
Q4 		$999K Buy
+22,008
New +$1.48M 0.38% 56

Other funds holding ONCT

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return

Quantum Private Wealth's ONCT Position: Q4 2024 in Review

Quantum Private Wealth sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2024, closing a stake of 13,187 shares — an estimated $17.4K sold.

Quantum Private Wealth first reported a position in ONCT in Q4 2021 and held it in 11 quarters. The position peaked at $999K in Q4 2021. 4 funds tracked by Wall St. Rank hold ONCT as of Q4 2024.

  • Quantum Private Wealth reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Quantum Private Wealth sold 13,187 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $17.4K.
  • Quantum Private Wealth first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Quantum Private Wealth's Oncternal Therapeutics, Inc. Common Stock position peaked at $999K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Quantum Private Wealth's 13F filing for Q4 2024, filed 30 Jan 2025.